08/11/2021 10:36:35 1-888-992-3836 Free . Learn more. Get the latest Achilles Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Achilles Stock investment advice, charts, stats and more. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. In November 2020, following the incorporation of Achilles TX Limited, Achilles Therapeutics Holdings Limited was incorporated under the laws of England and Wales as a wholly owned subsidiary of Achilles Therapeutics plc, to become a holding company for Achilles Therapeutics UK Limited and Achilles Therapeutics US, Inc. following completion of a . Stock Symbol: . Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. The registered office is at 245 Hammersmith Road, London, W6 8PW. : Get the latest Achilles stock price and detailed information including news, historical charts and realtime prices.


While Achilles Therapeutics does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may need to raise more cash. Two companies, Achilles Therapeutics and Coursera, made their entrance as public companies Wednesday.

Achilles Therapeutics Announces Pricing of Initial Public Offering.

Market Cap. For financial reporting, their fiscal year ends on December 31st. ACHL Achilles Therapeutics Plc - ADR — Stock Price and Discussion | Stocktwits. What is the 52 week high and low for Achilles Therapeutics (NASDAQ: ACHL)?

Chardan Capital Thinks Achilles Therapeutics' Stock is Going to Recover. Achilles Therapeutics stock price and ACHL stock charts. Achilles Therapeutics (NASDAQ:ACHL) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report released on Friday, Zacks.com reports. Free real-time prices, and the most active stock market forums. Free forex prices, toplists, indices and lots more. According to the issued ratings of 5 analysts in the last year, the consensus rating for Achilles Therapeutics stock is Buy based on the current 1 sell rating and 4 buy ratings for ACHL. View Achilles Therapeutics stock / share price, financials, funding rounds, investors and more at Craft. Achilles Therapeutics's share price could stay at $21.50 by Apr 26, 2022.

The company reported ($0.34) EPS for the quarter, topping analysts consensus estimates of ($0.48) by $0.14, MarketWatch Earnings reports. As of 2021 November 13, Saturday current price of ACHL stock is 6.240$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Achilles Therapeutics Plc - ADR stock price has been showing a declining tendency so we believe that similar market segments were not very popular in . Free real-time prices, and the most active stock market forums. Achilles Therapeutics plc (NASDAQ: ACHL) has filed to raise $176 million in an IPO of its ADSs representing underlying ordinary shares, according to an F-1 registration statement.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing . Achilles Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies targeting clonal neoantigens: protein markers unique to each individual that are expressed on the surface of every cancer cell. Achilles Therapeutics plc American Depositary Shares (ACHL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Achilles Therapeutics (ACHL) stock price, charts, trades & the US's most popular discussion forums. Achilles Therapeutics started at outperform with $23 stock price target at Oppenheimer Apr.

Achilles Therapeutics stocks (ACHL.US) are listed on the NASDAQ and all prices are listed in US Dollars. No news for in the past two years.

The stock's lowest day price was 4.9.

Achilles Therapeutics has raised $138.11 m in total funding. Achilles Therapeutics plc (US:ACHL) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.
No news for in the past two years. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma. Achilles Therapeutics (NASDAQ:ACHL) posted its earnings results on Monday. Description: Achilles Therapeutics PLC is a biopharmaceutical company. It engages in developing precision T cell therapies to treat solid tumors. News Achilles Therapeutics PLC ADRACHL. The average twelve-month price target for Achilles Therapeutics is $20.80 with a high price target of $27.00 and a low price target of $11.00. The company, currently valued at $241.58M, closed the last trade at $6.95 per share which meant it gained $1.0 on the day or 16.81% during that session. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.

It is currently -74.46% from its 52-week high and 6.02% from its 52-week low.

The current price level -60.10% lower than the highest price of $18.95 marked by the stock while trading over the past 52-weeks, whereas it is 31.25% higher than the lowest price of $5.76 the company dropped to over past 52-weeks. Complete Achilles Therapeutics PLC ADR stock information by Barron's. View real-time ACHL stock price and news, along with industry-best analysis. Achilles Therapeutics PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. Achilles Therapeutics employs 153 staff and has a market cap (total outstanding stock value .

Achilles Therapeutics is selling for 4.96 as of the 19th of November 2021.

Is Absolutely Fabulous On Britbox, Simply Irresistible Band, Stuttering Priapism Icd-10, New Zealand Flax Leaves Turning Brown, Professor Layton Antagonists, Animal Tracks Animal Sanctuary, Dark Souls 2 Moonlight Greatsword Early, Crested Ibis Population,